Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species
Files in This Item:
|Human_metabolites_of_the_anticancer_drug_flutamide_in_Cunninghamella_species_BILE_SEPT2010_R2.doc||458 kB||Microsoft Word||Download|
|Title:||Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species||Authors:||Amadio, Jessica
Murphy, Cormac D.
|Permanent link:||http://hdl.handle.net/10197/4302||Date:||1-Feb-2011||Online since:||2013-05-01T10:40:59Z||Abstract:||Fungi belonging to the genus Cunninghamella have enzymes similar to those employed by mammals for the detoxification of xenobiotics, thus they are useful as models of mammalian drug metabolism, and as a source for drug metabolites. We report the transformation of the anti-cancer drug flutamide in Cunninghamella sp. The most predominant phase I metabolites present in the plasma of humans, 2-hydroxyflutamide and 4-nitro-3-(trifluoromethyl)aniline, were also produced in Cunninghamella cultures. Other phase I and phase II metabolites were also detected using a combination of HPLC, GC–MS and 19F-NMR.||Type of material:||Journal Article||Publisher:||Springer Netherlands||Journal:||Biotechnology Letters||Volume:||33||Issue:||2||Start page:||321||End page:||326||Copyright (published version):||2011, Springer Netherlands||Keywords:||Biotransformation; Cytochrome P450; Fluorine-19 NMR; Sulfotransferase||DOI:||10.1007/s10529-010-0425-3||Language:||en||Status of Item:||Not peer reviewed|
|Appears in Collections:||Biomolecular and Biomedical Science Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.